The active ingredient present in the Ledercort 4 mg tablet is Triamcinolone acetonide, an anti-inflammatory corticosteroid that shows anti-neuropathic and neuroprotective effects in vivo. Triamcinolone acetonide is an apoptotic agent and is orally active.
The medicine is a corticosteroid, prescribed for arthritis, blood, skin, kidney, thyroid, eye, intestinal disorders, severe allergies and asthma. Triamcinolone acetonide prevents the release of substances in the body that cause inflammation.
Mechanism of action of the drug:
The administration of Triamcinolone acetonide stops the production of inflammatory mediators. It stops the biosynthesis of leukotrienes and prostaglandins as these plays a key role in producing undesired allergic signs and symptoms. Triamcinolone acetonide possesses an anti-inflammatory mechanism of action.
- The dosage of the drug is solely decided by the physician after assessing your medical condition and various factors such as disease condition, body weight, age, and gender. One cannot fix the dose of Triamcinolone acetonide, as it varies from patient to patient.
- Ledercort tablet should be taken exactly as recommended by your physician. Swallow the tablet with one glass of water. Try not to crush or chew the Ledercort 4 mg tablet.
- Always take the medicine as instructed by your pharmacist. Do not consume the Ledercort tablets in a greater amount. The intake of medicine depends on the condition of the patient. So, your doctor will recommend the best therapeutic dose for you. Consult your physician, before consuming the medicine.
- Always ask your doctor, before stopping the intake of the medicine.
In case of any adverse reactions, stop taking the medicine and talk to your physician immediately. You may observe common adverse reactions such as bruising of the skin, increased hair growth, insomnia, headache, stomach upset, vomiting, and irregular menstrual period, etc.
Precautions: a few things to remember
- Triamcinolone acetonide is contraindicated in patients with known hypersensitivity to any excipients in the formulations.
- Clinical experience with Triamcinolone acetonide in pregnant women is limited, but still it should not be administered during pregnancy unless the therapeutic advantage to the pregnant women is considered to outweigh the potential risk of the foetus.
- Infants born to mothers, who have received substantial doses of Ledercort should be carefully monitored for hypoadrenalism.
- It may, like another corticosteroid, pass into breast milk. Therefore, Triamcinolone acetonide should not administer to nursing women unless the therapeutic advantage to the nursing mother is considered to outweigh the potential risk of the infant.